References
- Ohwaki T., Nakamura M., Ozawa H., Kawashima Y., Hino T., Takcuchi H., Niwa T. Drug release from the water-in-oil-in water multiple emulsion in vitro. Chem. Pharm. Bull. 1993; 41: 741–746
- Morimoto Y., Sugibyash K., Yamaguchi Y., Kato Y. Detoxification capacity of a multiple (W/O/W) emulsions for the treatment of drug overdose: Drug extraction into the emulsions in the gastrointestinal tracts of rabbits. Chem. Pharm. Bull. 1979; 27: 3188–3192
- Omotosho J. A., Florence A. T., Whatelley T. L. Absorption and uptake lymphatic of 5-fluorouracil in the rat following oral adminstration of W/O/W multiple emulsion. Int. J. Pharm. 1990; 61: 51–56
- Fukushima S., Nishda M., Nakano M. Preparation of and drug release from W/O/W type double emulsions containing anticancer agents. Chem. Pharm. Bull. 1987; 35: 3375–3381
- Sela Y., Magdassi S., Garti N. Release of markers from the inner water phase of W/O/W emulsions stabilized by silicone based polymeric surfactants. J. Contr. Release 1995; 33: 1–12
- Ferreira L. A. M., Seiller M., Grossiord J. L., Marty J. P., Wepierre J. Vehicle influence on in vitro release of glucose: W/O, W/O/W and O/W system compared. J. Contr. Release 1995; 33: 349–356
- Goto S., Nakata K., Miyakawa T., Zhang W. T. Uchida, Releasing properties of water soluble drug in internal water phase of W/O/W multiple emulsions. Yakugaku Zasshi 1991; 111: 702–708
- Kim C. K., Kim S. C., Shin H. J., Kim K. M., Oh K. H., Lee Y. B., Oh I. J. Preparation and characterization of cytarabine-loaded W/O/W multiple emulsions. Int. J. Pharm. 1995; 124: 61–67
- Yoshioka T., Ikeuchi K., Hashida M., Muranish S., Sezaki H. Prolonged release of bleomycin from parenteral gelatin sphere-in-oil-in-water multiple emulsion. Chem. Pharm. Bull 1982; 30: 1408–1415
- Law S. L., Lin F. M. Release of metotrexate from microsphere-in-oil-in-water emulsions. Drug Dev. Ind. Pharm. 1991; 17: 919–930
- Burger J. J., Tomlinson E., Mulder E. M. A., McVie J. G. Albumin microspheres for intra-arterial tumor targeting. 1. Pharmaceutical aspects. Int. J. Pharm. 1985; 23: 333–344
- Lee Y. B., Koh I. K. Lymphatic delivery of oral anticancer tegafur by emulsion formulation. J. Kor. Pharm. Sci. 1993; 23: s19–s30
- Lee Y. B., Nam K. H., Chang W. I., Oh I. J., Koh I. B. Mesenteric lymphatic delivery of oral anticancer tegafur by emulsion formulation. J. Kor. Pharm. Sci. 1995; 25: 55–62
- Valdivieso M., Bodey G. P., Gottlieb J. A., Freireich E. J. Clinical evaluation of ftorafur (pyrimidine-deoxyribosa N-1-2′-fluranidyl-5-fluorouracil. Cancer Res. 1976; 36: 1821–1824
- Wu A. T., Au J. C., Sadee W. Hydroxylated metabolites of R, s-1-(tctrahydro-2-furanyl)-5-fluorouracil (Tegafur) in rats and rabbits. Cancer Res. 1978; 38: 210–225